User profiles for J Simon

Jeremy M. Simon

- Verified email at ds.dfci.harvard.edu - Cited by 24333

Javier Simón-Sánchez

- Verified email at dzne.de - Cited by 23060

Jacques Simon

- Verified email at unice.fr - Cited by 9913

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

…, S Jarius, M Lana-Peixoto, M Levy, JH Simon… - Neurology, 2015 - AAN Enterprises
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). …

Topological photonics

…, L Lu, MC Rechtsman, D Schuster, J Simon… - Reviews of Modern …, 2019 - APS
… where the first term describes hopping between nearestneighboring sites of the honeycomb
lattice, with hopping amplitude J, where FðtÞ ¼ F½cosðΩtÞex þ sinðΩtÞey reflects the …

Mechanisms of polycomb gene silencing: knowns and unknowns

JA Simon, RE Kingston - Nature reviews Molecular cell biology, 2009 - nature.com
Polycomb proteins form chromatin-modifying complexes that implement transcriptional silencing
in higher eukaryotes. Hundreds of genes are silenced by Polycomb proteins, including …

[HTML][HTML] Nivolumab versus everolimus in advanced renal-cell carcinoma

…, J Larkin, A Ravaud, JS Simon… - … England Journal of …, 2015 - Mass Medical Soc
Background Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated
with encouraging overall survival in uncontrolled studies involving previously treated …

[BOOK][B] The ultimate resource 2

JL Simon - 1996 - degruyter.com
… In Simon's view, the key factor in natural and world economic … he would encounter, Simon
nevertheless wrote The Economics … We should also add, in honor of Simon, the courage to use …

[HTML][HTML] Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

C Paisán-Ruı́z, S Jain, EW Evans, WP Gilks, J Simón… - Neuron, 2004 - cell.com
Parkinson's disease (PD; OMIM #168600) is the second most common neurodegenerative
disorder in the Western world and presents as a progressive movement disorder. The …

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna… - Nature, 2009 - nature.com
Chronic infection with hepatitis C virus (HCV) affects 170 million people worldwide and is
the leading cause of cirrhosis in North America 1 . Although the recommended treatment for …

[HTML][HTML] Functional discovery via a compendium of expression profiles

…, DD Shoemaker, D Gachotte, K Chakraburtty, J Simon… - Cell, 2000 - cell.com
Ascertaining the impact of uncharacterized perturbations on the cell is a fundamental problem
in biology. Here, we describe how a single assay can be used to monitor hundreds of …

[HTML][HTML] The accessible chromatin landscape of the human genome

…, A Safi, ME Sanchez, A Sanyal, A Shafer, JM Simon… - Nature, 2012 - nature.com
DNase I hypersensitive sites (DHSs) are markers of regulatory DNA and have underpinned
the discovery of all classes of cis-regulatory elements including enhancers, promoters, …

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

…, DE Goodkin, CV Granger, JH Simon… - Annals of Neurology …, 1996 - Wiley Online Library
The accepted standard treatment of relapsing multiple sclerosis consists of medications for
disease symptoms, including treatment for acute exacerbations. However, currently there is …